163 related articles for article (PubMed ID: 33069100)
1. Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer.
Czogalla B; Partenheimer A; Badmann S; Schmoeckel E; Mayr D; Kolben T; Beyer S; Hester A; Burges A; Mahner S; Jeschke U; Trillsch F
Transl Oncol; 2021 Jan; 14(1):100910. PubMed ID: 33069100
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.
Czogalla B; Deuster E; Liao Y; Mayr D; Schmoeckel E; Sattler C; Kolben T; Hester A; Fürst S; Burges A; Mahner S; Jeschke U; Trillsch F
Histochem Cell Biol; 2020 Oct; 154(4):421-429. PubMed ID: 32572587
[TBL] [Abstract][Full Text] [Related]
3. Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway.
Liao Y; Badmann S; Kaltofen T; Mayr D; Schmoeckel E; Deuster E; Mannewitz M; Landgrebe S; Kolben T; Hester A; Beyer S; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34206491
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
5. Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer.
Kaltofen T; Preinfalk V; Schwertler S; Fraungruber P; Heidegger H; Vilsmaier T; Vattai A; Czogalla B; Mayr D; Mahner S; Jeschke U; Trillsch F
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2559-2574. PubMed ID: 32681294
[TBL] [Abstract][Full Text] [Related]
6. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer.
Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y
Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316
[TBL] [Abstract][Full Text] [Related]
7. beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.
Kildal W; Risberg B; Abeler VM; Kristensen GB; Sudbø J; Nesland JM; Danielsen HE
Eur J Cancer; 2005 May; 41(8):1127-34. PubMed ID: 15911235
[TBL] [Abstract][Full Text] [Related]
8. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
[TBL] [Abstract][Full Text] [Related]
9. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
[TBL] [Abstract][Full Text] [Related]
10. Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology.
Czogalla B; Kahaly M; Mayr D; Schmoeckel E; Niesler B; Hester A; Zeder-Göß C; Kolben T; Burges A; Mahner S; Jeschke U; Trillsch F
Cancer Manag Res; 2019; 11():7673-7684. PubMed ID: 31616183
[TBL] [Abstract][Full Text] [Related]
11. Expression of selected epithelial-mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers.
Sadlecki P; Jóźwicki J; Antosik P; Grabiec M
Tumour Biol; 2018 Jun; 40(6):1010428318784807. PubMed ID: 29952249
[TBL] [Abstract][Full Text] [Related]
12. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
13. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.
Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z
Oncotarget; 2015 Nov; 6(34):35813-29. PubMed ID: 26452130
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
15. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
[TBL] [Abstract][Full Text] [Related]
16. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
19. Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer.
Psyrri A; Kotoula V; Fountzilas E; Alexopoulou Z; Bobos M; Televantou D; Karayannopoulou G; Krikelis D; Markou K; Karasmanis I; Angouridakis N; Kalogeras KT; Nikolaou A; Fountzilas G
Oral Oncol; 2014 Apr; 50(4):298-305. PubMed ID: 24461629
[TBL] [Abstract][Full Text] [Related]
20. Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome.
Grabsch H; Takeno S; Noguchi T; Hommel G; Gabbert HE; Mueller W
Histopathology; 2001 Aug; 39(2):141-9. PubMed ID: 11493330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
